Doxofylline
- Generic Name
- Doxofylline
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C11H14N4O4
- CAS Number
- 69975-86-6
- Unique Ingredient Identifier
- MPM23GMO7Z
- Background
Doxofylline is a methylxanthine derivative with the presence of a dioxolane group in position 7. As a drug used in the treatment of asthma, doxofylline has shown similar efficacy to theophylline but with significantly fewer side effects in animal and human studies. In contrast with other xanthine derivatives, doxofylline does not significantly bind to adenos...
- Indication
Indicated for the treatment of chronic obstructive pulmonary disease (COPD), bronchial asthma and pulmonary disease with spastic bronchial component.
- Associated Conditions
- Bronchial Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Disorder
- Associated Therapies
- -
Bronchodilator Effect of Oral Doxofylline and Procaterol in Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2024-04-04
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Thammasat University
- Target Recruit Count
- 20
- Registration Number
- NCT06346691
Effect of add-on Doxofylline on Lung Function in Stable COPD
- First Posted Date
- 2020-01-23
- Last Posted Date
- 2020-03-30
- Lead Sponsor
- University of Milan
- Target Recruit Count
- 78
- Registration Number
- NCT04238221
- Locations
- 🇮🇹
L. Sacco Hospital, Milan, Italy
Efficacy Of Doxophylline As A Sparing Treatment For Inhaled Corticosteroids In Mexican Children With Asthma
- First Posted Date
- 2019-03-19
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Universidad Autonoma de Nuevo Leon
- Target Recruit Count
- 60
- Registration Number
- NCT03879590
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath